Chronic Pain PhD | Mechanisms and Long-Term Effects of Spinal Cord Stimulation

Chronic Pain PhD | Mechanisms and Long-Term Effects of Spinal Cord Stimulation

Quick Decision

This is a focused, full-time, three-year Newcastle University studentship asking how spinal cord stimulation (SCS) engages neural activity and why its effects may change over time. Its advertised work combines behavioural, molecular and neurobiological perspectives in preclinical rat models, with particular interest in neural recruitment, analgesia, axonal homeostasis and longer-duration effects. The strongest academic fit is likely a neuroscience, pharmacology, physiology or biomedical-science graduate with evidence of research preparation; a research-trained Master's is advantageous, not required.

The opportunity has a relevant supervisory publication record and a clear translational question. Its immediate constraints are material: funding is limited to Home students; the deadline is 3 December 2026; and the application instructions name portal entry year 2026 even though April 2027 is the preferred start. Later-year stipend amounts and the coverage of research and other costs require confirmation from the university. Before investing in a full application, clarify Home status and the correct entry year with Newcastle. At interview or before accepting, verify supervisor roles, the collaborator's governance arrangements, and the multi-year funding and research-cost terms.

Research Problem and Doctoral Work

SCS is used for selected chronic neuropathic pain, but its biological effects and the reasons benefit can vary or decline over time are not fully resolved. The project is designed to connect three levels: the stimulation paradigm, the neural activity it recruits, and changes in pain-related outcomes. That question remains relevant because clinical evidence does not settle which paradigms are best for which outcomes, and the evidence for longer-term effects is less certain than a simple account of efficacy would suggest. A 2026 review of randomized trials reports benefits in some comparisons with conventional management while grading key outcomes as low certainty and finding paradigm comparisons uncertain; Cochrane likewise identifies limitations in longer-term evidence. 2026 network meta-analysis, Cochrane review.

The advertised doctoral work is to compare SCS paradigms at a broad level; relate neural recruitment and neuronal activity to pain processing and analgesia; investigate why efficacy may change, including axonal homeostasis as a candidate explanation; and develop longer-duration preclinical models so sustained neurobiological adaptations can be examined. Behavioural, molecular and neurobiological approaches are named. The description refers to extending model duration from minutes to days, but does not provide a student-specific work-package plan. Which questions and methods make up the student's core work should therefore be confirmed rather than assumed.

The scientific value will depend on whether response measures and pain-related outcomes can be interpreted together over time, while keeping model limits explicit. A recent review of preclinical SCS models finds substantial heterogeneity and highlights translation from animals to people as a continuing challenge. The proposed work may help clarify mechanisms under controlled preclinical conditions; it cannot by itself establish sustained clinical effectiveness or determine who should receive SCS. Review of preclinical SCS models, NICE evidence review.

School, Programme and Field Context

Newcastle University is the stated degree-awarding institution. The application route names the full-time PhD Translational and Clinical Research (course code 8440F); the project names an external company as a collaborator, not as a joint degree-awarding institution. The exact academic unit for registration and any project-specific arrangements remain unconfirmed. Newcastle PhD information, Translational and Clinical Research Institute postgraduate study.

The Institute describes a postgraduate research community of around 250, support through the Faculty Graduate School and Doctoral College, supervision and mentorship, research and career development, seminars, conferences and clinical links. Newcastle's neuroscience theme includes cellular, circuit and network neuroscience as well as chronic pain. These are relevant institutional context, but do not prove that any particular facility or training activity is allocated to this studentship. The University's general guidance gives a typical full-time PhD duration of three to four years, while this award lists three funded years. Annual progress review is part of the PGR framework, with the first review usually around nine months after registration; maximum registration, writing-up time and extension rules need confirmation for this project. Neuroscience research theme, Annual Progress Review, PGR Code of Practice.

For broad context, Newcastle is ranked 149th overall in the QS World University Rankings 2027 and 88th for Medicine in the QS 2026 subject rankings. Medicine is broader than pain neuroscience; neither figure assesses this research group. The University's REF 2021 summary is also institution-wide, rather than a project or lab rating. QS overall ranking, QS subject rankings, REF 2021 overview.

Supervisor and Lab Assessment

Dr Ilona Obara is a Reader in Pain Pharmacology and Neuroscience and the School of Pharmacy's Director of Research. Her profile describes chronic-pain and preclinical SCS interests, giving the project direct thematic alignment. It also states that she collaborates with Saluda Medical and serves on its Scientific Advisory Board. Dr Alexander (“Sasha”) Kraskov is a Senior Research Fellow and PI whose public profile emphasizes motor control and descending pathways. Recent joint SCS papers support his relevance, but the public profile does not set out his supervisory responsibilities for this project. Obara profile, Kraskov profile.

Recent papers help show what the group has established and what remains open:

• A 2026 study connects an objective neural-response measure with dorsal-column activation and analgesic effects in a preclinical pain model. It directly informs the project's neural-recruitment question, but does not establish long-term human efficacy. Study of neural activation and analgesia.
• A 2026 paper co-authored by both named supervisors characterizes electrophysiological signals in preclinical SCS models. This supports the team's measurement experience; signal characterization alone does not show durable analgesia. Study of epidural spinal signals.
• A 2026 preclinical paper reports that neural-response morphology varies with paradigm and recovery state. This gives a conceptual basis for questions about sustained effects and neural homeostasis, but does not explain multi-day loss of benefit in patients. Study of preclinical neural-response morphology.
• A 2024 group paper describes objective response measurement in a preclinical neuropathic-pain model. It supports prior model and measurement experience, rather than evidence of long-term clinical efficacy. Preclinical closed-loop SCS study.

Several recent papers disclose company affiliations, financial interests or research support associated with the external collaborator. This is relevant context for a translational partnership, not evidence of misconduct. Applicants should ask what the collaborator contributes and how data access, intellectual property, publication review and academic independence are handled. Named project facilities, equipment access, technical support, and the intended division of supervision are not established by the public profiles or papers.

Funding, Application, and Living Cost

The project describes one full-time award for three years, restricted to UK Home students. It states 100% coverage of Home tuition fees and a UKRI-rate stipend of £21,805 for 2026/27. UKRI confirms the 2026/27 minimum stipend and fee-rate context; later award amounts and research support remain unconfirmed. The student's written award terms should settle whether the stipend is indexed in later years and whether research, travel or extension costs are covered. Newcastle funding record for TC136, UKRI studentship guidance.

The stated stipend is about £1,817 per month when divided by 12. Newcastle's October 2026 illustrative monthly figures include university postgraduate accommodation at £470–£959, groceries £144, socialising £99, mobile £16, and course costs around £11–£59. Those selected items total roughly £729–£1,218 before transport, other bills, personal costs and contingencies; they are not a complete personal budget. Check accommodation type and actual costs against the stipend rather than treating the published examples as a guaranteed budget. Newcastle living-cost guide.

The deadline is 3 December 2026. The supplied application instructions say to apply through Newcastle's postgraduate portal, select Postgraduate Research / full-time, choose Year of Entry 2026, select course 8440F, enter project reference TC136, and put the project title in the proposal field; a separate research proposal is not requested. A current CV and covering letter are required. However, April 2027 is the preferred start, so the portal's 2026 entry-year instruction needs written clarification before submission. Newcastle application portal.

Applicant Fit and Preparation

Formal requirements: Home-student eligibility for this award and a relevant 2:1 honours degree or international equivalent.

Preferred experience: A Master's degree with a strong research-training component is described as highly advantageous, not mandatory.

Suggested preparation: Applicants from neuroscience, pharmacology, physiology, biomedical science or a related field can make the fit clearer by connecting prior research or coursework to pain mechanisms, neural activity and translational questions. The supplied instructions do not make any particular programming, animal-research or laboratory skill a formal requirement; do not present those as mandatory. A concise covering letter can explain research preparation, analytical judgement and interest in integrating different kinds of biological evidence.

The UK life-sciences sector assessment points to broad demand for specialist scientific and data skills, but it is not a neuroscience-specific vacancy forecast and cannot predict a graduate's employment. The project may provide transferable experience in neuroscience, neurophysiology and translational collaboration; career outcomes will also depend on the student's outputs and later opportunities. Skills England life-sciences assessment.

Next Actions and Questions to Verify

Before Applying

1. Ask Newcastle to confirm whether the applicant meets Home-fee status for this specific award.
2. Resolve which Year of Entry to select for the preferred April 2027 start.
3. Confirm that the live award still offers the stated Home-fee coverage, three-year duration and £21,805 2026/27 stipend, and ask how later years are indexed.
4. Confirm that the portal proposal field accepts the project title alone and check the required attachments.
5. Submit the application by 3 December 2026, if eligibility and timing are confirmed.

At Interview

• How are Obara's and Kraskov's supervisory roles divided, and what meeting structure is expected?
• Which broad questions and approaches would form the student's core work, and how are behavioural, molecular and neurobiological components balanced?
• What welfare oversight applies to any animal work, and what support or training is available?
• What is Saluda Medical's role, and how are data access, intellectual property and publication review governed?
• Which facilities, equipment and technical support are specifically available to the project?

Before Accepting an Offer

• Obtain written confirmation of the complete stipend and fee schedule, research-cost support, and any extension or writing-up arrangements.
• Confirm the academic unit, registration rules, maximum candidature period and named facilities.
• Review the collaborator agreement or a clear summary of its publication, data and intellectual-property terms.

Evidence and Sources

Project, programme, funding and costs

• Newcastle University funding record for TC136
• Newcastle postgraduate application portal
• UKRI studentship guidance for 2026/27 rates
• Newcastle student living-cost guide
• PhD and doctoral study at Newcastle
• Translational and Clinical Research Institute postgraduate study
• Newcastle Annual Progress Review
• Code of Practice for Research Degree Programmes

School, research environment and rankings

• Newcastle neuroscience research theme
• Newcastle QS World University Rankings
• Newcastle QS subject rankings 2026
• Newcastle REF 2021 overview

Supervisors and research papers

• Dr Ilona Obara profile
• Dr Alexander Kraskov profile
• Neural activation and analgesia in a preclinical model
• Electrophysiological signals in preclinical SCS models
• Preclinical neural-response morphology study
• Objective response measurement in a preclinical pain model

Clinical evidence, translation and careers

• 2026 randomized-trial network meta-analysis
• Cochrane review of spinal cord and dorsal root ganglion stimulation
• NICE evidence review of spinal cord stimulation
• Review of preclinical models and translational limits
• Skills England life-sciences sector assessment
• Review of SCS mechanisms